J&J Sues Boston Scientific, Abbott For $5.5 Bil For Breach Of Contract
This article was originally published in The Pink Sheet Daily
After losing bidding war for Guidant, J&J charges winning firms with using leaked information.
You may also be interested in...
Some state lawmakers contend that industry's voluntary code of ethics is insufficient, according to Kyphon's chief compliance officer.
Agency compliance head Tim Ulatowski says he's not concerned about the scientific exchange of information on products.
Defendant Metabolite argued that validity of patenting a natural phenomenon would have broader implications within the pharmaceutical, device and diagnostics industries.